The role of the E3 ubiquitin ligase FBXO7-SCF in early-onset Parkinson's disease

by David Brockelt
Doctoral thesis
Date of Examination:2015-11-19
Date of issue:2016-08-29
Advisor:Dr. Judith Stegmüller
Referee:Dr. Judith Stegmüller
Referee:Prof. Dr. Tiago Fleming Outeiro
Persistent Address: http://dx.doi.org/10.53846/goediss-5833

 

 

Files in this item

Name:Doctoral Thesis David Brockelt.pdf
Size:3.83Mb
Format:PDF

The following license files are associated with this item:

Abstract

English

Parkinson's disease (PD) is a debilitating movement disorder. Growing evidence associates genes with familial forms of the disease. Recently, gene mutations in the FBXO7 (PARK15) gene have been identified in patients with early-onset parkinsonism symptoms and pyramidal tract signs. PARK15 encodes for the E3 ubiquitin ligase FBXO7, whose function in the brain remains to be elucidated. In this study, I report that systemic loss of FBXO7 in mice results in an early-onset motor phenotype and premature death, reminiscent of the PARK15 patients. In neuropatholgical analyses, I find a regional increase in cell death and widespread astrogliosis. At the molecular level, I demonstrate the binding of FBXO7 to the proteasomal core subunit PSMA2 and identify PSMA as non-proteolytic ubiquitination substrate. Interestingly, I show that loss of FBXO7 in the brain leads to reduced proteasome activity as a consequence of defective proteasome integrity. Taken together, I established an FBXO7- dependent mechanism of proteasome regulation in neurons, which provides novel insight into the role of the UPS in PD.
Keywords: Biology
 
Statistik